The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing
Open accessThe DOI matches its Crossref record; 186 of the 187 references it cites were found in a registry or an index.
Abstract
Following the discovery of T helper 17 (TH17) cells, the past decade has witnessed a major revision of the TH subset paradigm and substantial progress has been made in deciphering the molecular mechanisms of T cell lineage commitment and function. In this Review, we focus on the recent advances that have been made regarding the transcriptional control of TH17 cell plasticity and stability, as well as the effector functions of TH17 cells, and we highlight the mechanisms of IL-17 signalling in mesenchymal and barrier epithelial tissues. We also discuss the emerging clinical data showing that IL-17-specific and IL-23-specific antibody treatments are remarkably effective for treating many immune-mediated inflammatory diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IL-17 induces IL-6 and G-CSF, cytokines that promote myeloid-driven innate inflammation”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Gaffen et al., 2014
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Natural and inducible TH17 cells are regulated differently by Akt and mTOR pathways
Kim, J. S., Sklarz, T., Banks, L. B., Gohil, M., Waickman, A. T., Skuli, N., Krock, B. L., Luo, C. T., Hu, W., Pollizzi, K. N., et al. (2013) · Nature Immunology · doi:10.1038/ni.2607 · Cited by 85
RetractedMosmann, T. R., & Coffman, R. L. (1989) · Annual Review of Immunology · doi:10.1146/annurev.iy.07.040189.001045 · Cited by 7,692
Mosmann, T. R., Cherwinski, H., Bond, M. W., Giedlin, M. A., & Coffman, R. L. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.7.2348 · Cited by 7,506
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992
Ivanov, I. I., McKenzie, B. S., Zhou, L., Tadokoro, C. E., Lepelley, A., Lafaille, J. J., Cua, D. J., & Littman, D. R. (2006) · Cell · doi:10.1016/j.cell.2006.07.035 · Cited by 5,145
Self-citationHarrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M., & Weaver, C. T. (2005) · Nature Immunology · doi:10.1038/ni1254 · Cited by 4,742
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y.-H., Wang, Y., Hood, L., Zhu, Z., Tian, Q., et al. (2005) · Nature Immunology · doi:10.1038/ni1261 · Cited by 4,265
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099
Self-citationVeldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M., & Stockinger, B. (2006) · Immunity · doi:10.1016/j.immuni.2006.01.001 · Cited by 3,605
Transforming growth factor-β induces development of the TH17 lineage
Mangan, P. R., Harrington, L. E., O'Quinn, D. B., Helms, W. S., Bullard, D. C., Elson, C. O., Hatton, R. D., Wahl, S. M., Schoeb, T. R., & Weaver, C. T. (2006) · Nature · doi:10.1038/nature04754 · Cited by 3,087
Research works printed but not linked: 1
- Ghoreschi K Generation of pathogenic T(H)17 cells in the absence of TGF-beta signalling Nature 467 967 971 20962846 PMC3108066 · DOI · Paper page
Cited by
Items 801–900 of 1,000
Is rheumatoid arthritis an autoimmune disease?
Chemin, K., Klareskog, L., & Malmström, V. (2016) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000253 · Cited by 22
“Interleukin (IL)-17 producing T cells (Th17 subset) have also been identified in synovial fluids from RA patients [64,65] and a number of studies describe their implication in inflammatory disorders [66].”
BackgroundRezaeepoor, M., Hoseini-Aghdam, M., Sheikh, V., Eftekharian, M. M., & Behzad, M. (2020) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2020.0113 · Cited by 21
The role of infected epithelial cells in Chlamydia-associated fibrosis
Caven, L. T., & Carabeo, R. A. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1208302 · Cited by 21
Interleukin-23 Involved in Fibrotic Autoimmune Diseases: New Discoveries
Sisto, M., & Lisi, S. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12175699 · Cited by 21
“Although the role of IL-23 in the immune response during bacterial and viral infections has recently been evaluated, demonstrating its central role [7], its deregulation has been demonstrated to aggravate chronic inflammatory status, contributing to the development of autoimmune diseases [8,9].”
BackgroundLi, X., Liu, T., Mo, X., Wang, R., Kong, X., Shao, R., McIntyre, R. S., So, K., & Lin, K. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.389360 · Cited by 21
“For example, if TH0 cells produce IL-6, the consequence is activation of Th17 cells, which secrete proinflammatory cytokines like IL-17, IL-21, and IL-22 (Gaffen et al., 2014).”
BackgroundInfluentialInterleukin inhibitors and the associated risk of candidiasis
Khan, S., Bilal, H., Khan, M. N., Fang, W., Chang, W., Yin, B., Song, N., Liu, Z., Zhang, D., Yao, F., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1372693 · Cited by 22
“The primary homeostatic function of the IL-23/IL-17 pathway in the host is to defend against fungal and bacterial pathogens at mucosal barriers, concurrently overseeing barrier function (28).”
BackgroundRole and functional mechanisms of IL‑17/IL‑17R signaling in pancreatic cancer (Review)
Liu, W., Wang, X., & Wu, W. (2024) · Oncology Reports · doi:10.3892/or.2024.8803 · Cited by 22
“Notably, the IL‑17‑induced posttranscriptional regulation of mRNA is a component of its self‑enhancement mechanisms, amplifying the activity of IL‑17 (55).”
BackgroundIL‐23R Deficiency Does Not Impact Atherosclerotic Plaque Development in Mice
Engelbertsen, D., Depuydt, M. A. C., Verwilligen, R. A. F., Rattik, S., Levinsohn, E. A., Edsfeldt, A., Kuperwaser, F., Jarolím, P., & Lichtman, A. H. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.117.008257 · Cited by 21
“5–7 IL-23 signals through the IL-23 receptor to stabilize and promote production of IL-17 and IFN-c in Th17 cells.(5) Furthermore, IL-23 is required for the generation of “pathogenic” IL-17IFN-c double-producing helper T cells that mediate tissue damage in models of autoimmune disease.”
BackgroundBösl, K., Giambelluca, M. S., Haug, M., Bugge, M., Espevik, T., Kandasamy, R. K., & Bergstrøm, B. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00618 · Cited by 21
“This not surprising as Th17 differentiation require both IL-6 and TGFβ (Veldhoen et al., 2006) and we did not observe any differential expression of TGFβ at mRNA level in our monocyte experiments although is possible that TGFβ is regulated at the translational level.”
BackgroundAutosomal dominant Hashimoto’s thyroiditis with a mutation in TNFAIP3
Hori, T., Ohnishi, H., Kadowaki, T., Kawamoto, N., Matsumoto, H., Ohara, O., & Fukao, T. (2019) · Clinical Pediatric Endocrinology · doi:10.1297/cpe.28.91 · Cited by 21
“Th17 and DNT are well known subsets of T lymphocytes that play a role in autoimmunity (16, 17).”
BackgroundWang, H., Nelson, A. G., Wang, B., Zhao, Z., Lim, X. Y., Shi, M., Meehan, L. J., Jia, X., Kedzierska, K., Meehan, B. S., et al. (2022) · Immunology and Cell Biology · doi:10.1111/imcb.12556 · Cited by 21
Chen, S., Zhang, X., Yang, C., Wang, S., & Shen, H. (2022) · Theranostics · doi:10.7150/thno.74809 · Cited by 21
“IL-17 is a pro-inflammatory cytokine that induces neutrophilic inflammation [14], which implies that IL-17 participates in the pathogenesis of AE-IPF.”
BackgroundRevisiting Coley’s Toxins: Immunogenic Cardiolipins from Streptococcus pyogenes
Shin, Y., Bang, S., Park, S., Ma, X., Cassilly, C. D., Graham, D. B., Xavier, R. J., & Clardy, J. (2023) · Journal of the American Chemical Society · doi:10.1021/jacs.3c07727 · Cited by 21
Can, M., Uygur, F., Tanrıverdi, H., Açıkgöz, B., Alper, B., & Güven, B. (2016) · Immunologic Research · doi:10.1007/s12026-016-8869-8 · Cited by 21
“specifically target IL-23 (antibodies to p19) are being developed [13].”
BackgroundIL-17A-dependent gut microbiota is essential for regulating diet-induced disorders in mice
Bi, Y., Li, C., Liu, L., Zhou, J., Li, Z., Deng, H., Wu, C., Han, Y., Song, Y., Tan, Y., et al. (2017) · 中国科学通报:英文版 · doi:10.1016/j.scib.2017.07.011 · Cited by 21
IL-17A – A regulator in acute inflammation: Insights from in vitro, in vivo and in silico studies
Sud, V., Abboud, A., Tohme, S. T., Vodovotz, Y., Simmons, R. L., & Tsung, A. (2018) · Cytokine · doi:10.1016/j.cyto.2018.03.030 · Cited by 21
Witjes, H., Khatri, A., Diderichsen, P. M., Mandema, J. W., & Othman, A. A. (2019) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1624 · Cited by 21
Niu, Y., Ye, L., Peng, W., Wang, Z., Wei, X., Wang, X., Li, Y., Zhang, S., Xiang, X., & Zhou, Q. (2021) · Journal of Leukocyte Biology · doi:10.1002/jlb.1ma0221-479rr · Cited by 21
Wang, L., & Sheng‐Kai, K. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-218995 · Cited by 21
Lee, S.-Y., Moon, S., Moon, Y., Seo, H.-B., Ryu, J., Lee, A. R., Lee, C. R., Kim, D., Her, Y., Choi, J. W., et al. (2021) · Cellular and Molecular Immunology · doi:10.1038/s41423-021-00798-2 · Cited by 20
“It is unclear whether this role involves the IL-12p40 subunit; however, unlike other IL-12 family cytokines, IL-12 and IL-23 exhibit mainly proinflammatory potential [2, 17].”
BackgroundTofacitinib for extraintestinal manifestations of inflammatory bowel disease: A literature review
Wang, Y., Wan, Z., Jin, R., Xu, T., Ouyang, Y., Wang, B., Ruan, G., & Bai, X. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.108517 · Cited by 20
Denis, A., Sztejkowski, C., Arnaud, L., Becker, G., & Felten, R. (2023) · RMD Open · doi:10.1136/rmdopen-2023-003279 · Cited by 20
Wu, Y., Luo, J., & Xu, B. (2023) · Current Research in Toxicology · doi:10.1016/j.crtox.2023.100139 · Cited by 20
“Some evidence suggests that IL-17A can increase the expression of PD-L1 and promote tumor progression in HCC or ovarian cancer (Gaffen et al., 2014; Monin & Gaffen, 2018; Wei et al., 2019).”
BackgroundZhu, J., Yin, J., Chen, J., Hu, M., Lu, W., Wang, H., Zhang, H., & Chen, W. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2336877 · Cited by 21
“72 IFN-γ has been reported to associate with increased epithelial cell apoptosis.”
BackgroundRamos, A. L., Goedken, E. R., Frank, K. E., Argiriadi, M. A., Bazzaz, S., Bian, Z., Brown, J. T. C., Centrella, P. A., Chen, H.-J., Disch, J. S., et al. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c02397 · Cited by 21
Meta-analysis of theIL23RandIL12Bpolymorphisms in multiple sclerosis
Huang, J., Yang, Y., Zhou, F.-M., Liang, Z., Kang, M., Kuang, Y., & Li, F. (2015) · International Journal of Neuroscience · doi:10.3109/00207454.2015.1007508 · Cited by 20
“It is essential for the survival and/or expansion of Th17 cells, which produce IL-17A, IL-17F, IL-22, and interferonγ (IFN-γ ) and are key mediators of inflammation and autoimmunity [9].”
BackgroundClarke, D. O., Hilbish, K. G., Waters, D. G., Newcomb, D. L., & Chellman, G. J. (2015) · Reproductive Toxicology · doi:10.1016/j.reprotox.2015.10.008 · Cited by 20
Multiple sclerosis genetics: Results from meta-analyses of candidate-gene association studies
Tizaoui, K. (2017) · Cytokine · doi:10.1016/j.cyto.2017.10.024 · Cited by 20
Galectin-9 Is Critical for Mucosal Adaptive Immunity through the T Helper 17–IgA Axis
Liang, C., Li, C.-S., Weng, I., Chen, H., Lu, H.-H., Huang, C., & Liu, F. (2018) · American Journal Of Pathology · doi:10.1016/j.ajpath.2018.01.017 · Cited by 20
“34,46 Therefore, it is reasonable to assume that impairment of the IL-23 e Th17 cell axis partly contributes to a higher mortality rate in Lgals9 (cid:2) / (cid:2) mice that receive high CT doses.”
BackgroundMicroRNA in T-Cell Development and T-Cell Mediated Acute Graft-Versus-Host Disease
Koenecke, C., & Krueger, A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00992 · Cited by 20
Wu, X., Zeng, Z., Gong, D., Wen, J., & Huang, F. (2019) · Biotechnic & Histochemistry · doi:10.1080/10520295.2019.1574028 · Cited by 20
“Th17 cells and related inflammatory factors, such as IL17, promote inflammation and autoimmune responses (Gaffen et al. 2014; Zhang et al. 2015; Whibley et al. 2016).”
BackgroundAl-Mutairi, N., & Eassa, B. I. (2019) · Advances in Dermatology and Allergology · doi:10.5114/ada.2019.91496 · Cited by 20
“rheumatoid arthritis, psoriasis, psoriatic arthritis, and ankylosing spondylitis [20, 21].”
BackgroundZhang, S., Wang, M., Wang, C., Wang, G., Sun, K., Xiong, S., Cheng, L., Yang, D., Lin, X., & Zhao, X. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2001031 · Cited by 20
“quimod- (IMQ) (3) or IL-23– (4) induced psoriatic mouse models, which proposed the so-called “IL-23/T17 axis” (5).”
BackgroundDrivers of Inflammation in Psoriatic Arthritis: the Old and the New
O’Brien-Gore, C., Gray, E. H., Durham, L. E., Taams, L. S., & Kirkham, B. W. (2021) · Current Rheumatology Reports · doi:10.1007/s11926-021-01005-x · Cited by 20
Heluany, C. S., Donate, P. B., Schneider, A. H., Fabris, A. L., Gomes, R. A., Villas-Boas, I. M., Tambourgi, D. V., Silva, T. A., Trossini, G. H. G., Nalesso, G., et al. (2021) · Antioxidants · doi:10.3390/antiox10060929 · Cited by 20
“The CD4+ T cell-secreted IL-17A can activate FLS, mature osteoclasts, and recruit neutrophils, macrophages and B cells to be activated [8,9].”
BackgroundElevated Serum Interleukin‐23 Levels in Patients with Oral and Cutaneous Lichen Planus
Mardani, M., Mofidi, H., Dastgheib, L., Ranjbar, S., & Hamidizadeh, N. (2021) · Mediators of Inflammation · doi:10.1155/2021/5578568 · Cited by 20
“The IL-23-activated Th17 cells promote chronic tissue inflammation, granuloma formation, and autoimmunity [36].”
Du, L.-J., Feng, Y., He, Z., Huang, L., Wang, Q., Wen, C., & Zhang, Y. (2021) · Acta Pharmacologica Sinica · doi:10.1038/s41401-021-00773-7 · Cited by 20
Yang, Y., Chen, Y., Yu, L., Zhang, X., Shang, J., Fan, J., Zhang, R., Ren, J., & Duan, X. (2022) · Inflammation Research · doi:10.1007/s00011-022-01674-z · Cited by 21
“Besides Th17 cells, IL-17 was also expressed in various subsets of lymphocytes, including γδ T cells [57], NK T cells [58], NK cells, CD8+ T cells, and three groups of innate lymphocytes (ILC3s)[59].”
BackgroundAssociation of endometriosis with Sjögren's syndrome: Genetic insights (Review)
Zervou, M. I., Tarlatzis, B. C., Grimbizis, G., Spandidos, D. A., Niewold, T. B., & Goulielmos, G. N. (2024) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2024.5344 · Cited by 20
“As a consequence, a promising therapeutic option may be JAK inhibitors that interrupt the transduction of the aforementioned JAK/STAT pathway (267,268).”
BackgroundUbiquitin Ligases and Deubiquitinating Enzymes in CD4+ T Cell Effector Fate Choice and Function
Layman, A. A. K., & Oliver, P. M. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1502660 · Cited by 20
“STAT3 is induced downstream of IL-6, IL-21, and IL-23 and cooperates with IRF4 (induced downstream of IL-1b) to elevate levels of RAR-related orphan receptor g T (RORgT) (64, 65).”
BackgroundZhao, Q. S., Harbour, S. N., Kolde, R., Latorre, I. J., Tun, H. M., Schoeb, T. R., Turner, H., Moon, J. J., Khafipour, E., Xavier, R. J., et al. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1700171 · Cited by 20
Hummel, T. M., Ackfeld, T., Schönberg, M., Ciupka, G., Schulz, F., Oberdoerster, A., Grötzinger, J., Scheller, J., & Floss, D. M. (2017) · Molecular and Cellular Biology · doi:10.1128/mcb.00014-17 · Cited by 20
“IL-23 acts as a pivotal factor for the differentiation and inflammatory functions of pathogenic TH17 cells (29).”
BackgroundIL-17 Promotes Pseudomonas aeruginosa Keratitis in C57BL/6 Mouse Corneas
Me, R., Gao, N., Dai, C., & Yu, F. X. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1900736 · Cited by 20
“IL-17 was first identified in 1993 and rose to prominence after the discovery of IL-17–secreting CD4 T cells in 2005 (21).”
BackgroundAnti-interleukin-17 treatment of psoriasis
Jinna, S., & Strober, B. E. (2016) · Journal of Dermatological Treatment · doi:10.3109/09546634.2015.1115816 · Cited by 20
“Genetic studies found a strong association of IL-23R with susceptibility to Crohn’s disease, thus implicating the IL-23-IL-17 axis in disease pathogenesis.”
BackgroundInfluentialPsoriasis and gut microbes: research advances from mechanism to therapy
Chen, J., Sun, K., Zhang, X., Chen, X., Chu, Y., Geng, L., Bian, Z., Su, Y., Cong, X., & Wang, G. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1711288 · Cited by 19
Guselkumab: an anti-IL-23 antibody for the treatment of moderate-to-severe plaque psoriasis
Chiricozzi, A., Costanzo, A., Fargnoli, M. C., Malagoli, P., Piaserico, S., Amerio, P., Argenziano, G., Balato, N., Bardazzi, F., Bianchi, L., et al. (2021) · European Journal of Dermatology · doi:10.1684/ejd.2021.3965 · Cited by 19
Peripheral Blood T Cells of Patients with IPAH Have a Reduced Cytokine-Producing Capacity
van Uden, D., Koudstaal, T., van Hulst, J. A. C., Vink, M., van Nimwegen, M., van den Toorn, L. M., Chandoesing, P. P., van den Bosch, A. E., Kool, M., Hendriks, R. W., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126508 · Cited by 19
“Th17 cells are known to play an important role in many inflammatory and autoimmune diseases [7,8] and were found in pulmonary tertiary lymphoid organs (TLOs) of IPAH patients [9].”
BackgroundHow Has Molecular Biology Enhanced Our Undertaking of axSpA and Its Management
Fatica, M., D’Antonio, A., Novelli, L., Triggianese, P., Conigliaro, P., Greco, E., Bergamini, A., Perricone, C., & Chimenti, M. S. (2022) · Current Rheumatology Reports · doi:10.1007/s11926-022-01092-4 · Cited by 19
Yan, B., Chen, X., Wang, Y., Yuan, M., Xian, J., Lu, D., Shao, Z., Qiu, M., Fu, T., & Zheng, X. (2024) · Journal of Functional Foods · doi:10.1016/j.jff.2024.106414 · Cited by 19
Orthodontic treatment mediates dental pulp microenvironment via IL17A
Yu, W., Zhang, Y., Jiang, C., He, W., Yi, Y., & Wang, J. (2016) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2016.01.009 · Cited by 19
Gene Expression Profile of Human Cytokines in Response to Burkholderia pseudomallei Infection
Krishnananthasivam, S., Sathkumara, H. D., Corea, E. M., Natesan, M., & Silva, A. D. D. (2017) · mSphere · doi:10.1128/msphere.00121-17 · Cited by 19
“Anti-IL-17 and anti-IL-23 antibodies have been shown to be effective in several immunemediated inflammatory diseases (18, 20).”
BackgroundThymic Program Directing the Functional Development of γδT17 Cells
Jouan, Y., Patin, E. C., Hassane, M., Si‐Tahar, M., Baranek, T., & Paget, C. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00981 · Cited by 19
Li, J., Kong, P., Chen, C., Tang, J., Jin, X., Yan, J., & Wang, Y. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/1475729 · Cited by 19
“IL-17, which is produced by many different cellular sources, initiates the production of other proinflammatory mediators and chemokines, collectively resulting in an influx of neutrophils [8].”
BackgroundEmerging therapies for the treatment of ulcerative colitis
Pugliese, N., Roda, G., Peyrin‐Biroulet, L., & Danese, S. (2020) · Expert Opinion on Emerging Drugs · doi:10.1080/14728214.2020.1737009 · Cited by 19
Getting Under the Skin: Targeting Cutaneous Autoimmune Disease.
Vesely, M. D. (2020) · The Yale Journal of Biology and Medicine · Cited by 19
Biaoxue, R., Fu, T., Rong, C., Liu, W., Li, K., & Liu, H. (2020) · Scientific Reports · doi:10.1038/s41598-020-73903-6 · Cited by 19
Santiago‐López, L., Hernández‐Mendoza, A., Vallejo‐Córdoba, B., Wall‐Medrano, A., & González-Córdova, A. F. (2021) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2021.03.051 · Cited by 19
Fermented food Tempeh induces interleukin 12 and enhances macrophage phagocytosis
Hosaka, Y., Itoh, K., Matsutani, S., Kawate, S., Miura, A., Mizoura, Y., Yamada, S., Konno, H., Grave, E., Nagata, K., et al. (2021) · Journal of Food Biochemistry · doi:10.1111/jfbc.13958 · Cited by 19
Butt, A. Q., McArdle, A., Gibson, D. S., FitzGerald, O., & Pennington, S. R. (2015) · Current Rheumatology Reports · doi:10.1007/s11926-015-0509-0 · Cited by 19
“Interleukin-17 has emerged as an important mediator of the disease, and it is understood that IL-23 regulates the production of this cytokine [37, 38].”
BackgroundNile, C. J., Apatzidou, D. A., Awang, R. A., Riggio, M. P., Kinane, D. F., & Lappin, D. F. (2016) · Clinical Oral Investigations · doi:10.1007/s00784-016-1749-8 · Cited by 19
“In addition, smokers have greater numbers of CD4+ IL-17+ T cells in the lung tissue than non-smokers [24].”
Layman, A. A. K., Sprout, S. L., Phillips, D., & Oliver, P. M. (2017) · Scientific Reports · doi:10.1038/srep39649 · Cited by 19
The complex alteration in the network of IL-17-type cytokines in patients with hereditary angioedema
Arcoleo, F., Pizzo, M. L., Misiano, G., Milano, S., Romano, G. C., Muggeo, V. M. R., & Cillari, E. (2018) · Clinical and Experimental Medicine · doi:10.1007/s10238-018-0499-0 · Cited by 19
Anti-inflammatory modulation of human myeloid-derived dendritic cell subsets by lenalidomide
Yamamoto, K., Kitawaki, T., Sugimoto, N., Fujita, H., Kawase, Y., Takaori‐Kondo, A., & Kadowaki, N. (2019) · Immunology Letters · doi:10.1016/j.imlet.2019.05.012 · Cited by 19
Standard dose of Ustekinumab for childhood-onset deficiency of interleukin–36 receptor antagonist
Cherqaoui, B., Rossi‐Semerano, L., Piram, M., & Koné‐Paut, I. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2017-212793 · Cited by 19
Li, C., Chen, L., Wang, L.-F., Yan, B., Liang, Y., & Luo, J. (2020) · International Journal of Ophthalmology · doi:10.18240/ijo.2020.04.19 · Cited by 18
The role of interleukin-17 in the pathogenesis of systemic sclerosis: Pro-fibrotic or anti-fibrotic?
Bellando-Randone, S., Della‐Torre, E., & Balanescu, A. R. (2021) · Journal of Scleroderma and Related Disorders · doi:10.1177/23971983211039421 · Cited by 19
Friend or Foe – Tc17 cell generation and current evidence for their importance in human disease
Hipp, A. V., Bengsch, B., & Globig, A.-M. (2023) · Discovery Immunology · doi:10.1093/discim/kyad010 · Cited by 18
“In addition to affecting the Tc17 program, IL-23 triggers other pro-inflammatory processes such as reduced T REG function and increased T cell production of TNF-α and GM-CSF [258, 264].”
BackgroundMado, H., Stasiniewicz, A., Adamczyk-Sowa, M. H., & Sowa, P. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252010931 · Cited by 18
“High levels of IL-12 and Th1 are reported in clinical samples among MS patients [44].”
BackgroundEmerging Concepts in Cytokine Regulation of Airway Remodeling in Asthma
Latayan, J., Akkenapally, S. V., & Madala, S. (2025) · Immunological Reviews · doi:10.1111/imr.70020 · Cited by 11
Su, Q., Zhang, X., Shen, X., Hou, Y., Sun, Z., & Gao, Z. H. (2018) · Journal of Cancer · doi:10.7150/jca.24200 · Cited by 18
“IFNa, TNF, IL-23/IL-17 inflammatory axis) [23-26], and NETosis, which cause harm to healthy cells [27].”
BackgroundZhuang, Y., Chen, Y., Zhou, S., Hu, P., Chen, Y., & Li, D. (2020) · BMC Cardiovascular Disorders · doi:10.1186/s12872-020-01451-y · Cited by 18
“The cardiovascular diseases, including atherosclerosis, hypertension, myocardial infarction and even atrial fibrillation, seemed to be tightly associated with the activated IL-17/23 axis [52].”
BackgroundInfluentialGoedken, E. R., Argiriadi, M. A., Dietrich, J. D., Petros, A. M., Krishnan, N., Panchal, S. C., Qiu, W., Wu, H., Zhu, H., Adams, A. M., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-18760-1 · Cited by 18
Chen, M., Chuang, H., Yeh, Y., Chou, C., & Tan, T. (2023) · BMC Medicine · doi:10.1186/s12916-023-02745-6 · Cited by 18
Tavasolian, F., & Inman, R. D. (2023) · Communications Biology · doi:10.1038/s42003-023-04743-z · Cited by 18
Psarelis, S., Hajineocli, A. P. D., Hadjicosta, E., Elliott, H. S. A., & Johnson, P. (2017) · Clinical Rheumatology · doi:10.1007/s10067-017-3573-1 · Cited by 18
Hernández-Mir, G., & McGeachy, M. J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0173655 · Cited by 18
The epigenetic regulator ATF7ip inhibits Il2 expression, regulating Th17 responses
Sin, J. H., Zuckerman, C., Cortez, J. T., Eckalbar, W. L., Erle, D. J., Anderson, M. S., & Waterfield, M. R. (2019) · The Journal of Experimental Medicine · doi:10.1084/jem.20182316 · Cited by 18
“Th17 cells are unique in their requirement to control pathogens at mucosal surfaces (Gaffen et al., 2014; Naglik et al., 2017).”
E3 Ubiquitin Ligase Von Hippel–Lindau Protein Promotes Th17 Differentiation
Chitrakar, A., Budda, S. A., Henderson, J. G., Axtell, R. C., & Zenewicz, L. A. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.2000243 · Cited by 18
“differentiation (15, 16, 51); IL-23 is required for the stabilization, expansion, and inflammatory function of Th17 cells, but not their initial differentiation (3).”
BackgroundTang, Z., Shi, J., Xu, S., Liu, S., Yin, W., Xiang, Y., Li, J., He, Z., Yao, X., Zhou, L., et al. (2025) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2025-011959 · Cited by 18
Kamperschroer, C., Collinge, M., Heyen, J. R. R., Ji, C., O’Donnell, L. M., & Zhu, X. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64229-0 · Cited by 17
Ustekinumab in the Treatment of Inflammatory Bowel Diseases: Evolving Paradigms
Mocci, G., Tursi, A., Onidi, F. M., Usai–Satta, P., Pes, G. M., & Dore, M. P. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13051519 · Cited by 17
“Therefore, a blockade of the IL-12/23 system, using a specific antibody, inhibits Th1-and Th17-mediated adaptive immune responses, which play a fundamental role in the pathogenesis of CD [16], as well as UC [17].”
BackgroundInnate Immune Response and Epigenetic Regulation: A Closely Intertwined Tale in Inflammation
Jawale, D., Khandibharad, S., & Singh, S. (2024) · Advanced Biology · doi:10.1002/adbi.202400278 · Cited by 17
Shi, W., Zhao, Z., Zhai, Y., Ye, X., & Feng, X. (2025) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-025-00837-y · Cited by 17
“IL-23 has been implicated in the pathogenesis of various autoimmune and inflammatory diseases, including but not limited to rheumatoid arthritis, psoriasis, inflammatory bowel disease, and multiple sclerosis [1].”
Papp, K. A., de Vente, S., Zeng, J., Flack, M., Padilla, B., & Tyring, S. K. (2021) · Dermatology and Therapy · doi:10.1007/s13555-021-00490-3 · Cited by 17
Asiatic acid exerts an anti-psoriatic effect in the imiquimod-induced psoriasis model in mice
Kukula, O., Kırmızıkan, S., Tiryaki, E. S., Çiçekli, M. N., & Günaydın, C. (2022) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923973.2022.2048849 · Cited by 17
“TNFalpha stimulation and STAT3 expression are accepted as significant mediators behind IL-17A and IL-23 response [25].”
BackgroundTopal, İ. O., Baysak, S., Altunay, İ. K., Polat, A. K., Arıkan, E. E., Özkur, E., Aytekin, S., Doğan, B., Akbulut, T. Ö., Demir, F. T., et al. (2022) · Anais Brasileiros de Dermatologia · doi:10.1016/j.abd.2021.11.002 · Cited by 17
Interleukin 17 and Its Involvement in Renal Cell Carcinoma
Jarocki, M., Karska, J., Kowalski, S., Kiełb, P., Nowak, Ł., Krajewski, W. R., Saczko, J., Kulbacka, J., Szydełko, T., & Małkiewicz, B. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11174973 · Cited by 17
“This IL-17R–Act1 complex cooperates as well with MEKK3 and MEK5 in a TRAF4-dependent manner that results in the activation of ERK5 [8].”
BackgroundInfluentialDecoupling the role of RORγt in the differentiation and effector function of T H 17 cells
Zhong, X., Wu, H., Zhang, W., Gwack, Y., Shang, W., Lee, K. O., Isakov, N., He, Z., & Sun, Z. (2022) · Science Advances · doi:10.1126/sciadv.adc9221 · Cited by 17
IEC-intrinsic IL-1R signaling holds dual roles in regulating intestinal homeostasis and inflammation
Overcast, G. R., Meibers, H. E., Eshleman, E. M., Saha, I., Waggoner, L., Patel, K. N., Jain, V. G., Haslam, D. B., Alenghat, T., VanDussen, K. L., et al. (2023) · The Journal of Experimental Medicine · doi:10.1084/jem.20212523 · Cited by 17
“CD103 + DCs and CX3CR1 + macrophages in the lamina propria respond to signals from the luminal content and produce IL-23, which then induce propagation of ILC3s and Th17 cells and induce their production of IL-22 (Muzaki et al., 2016; Parks et al., 2016).”
BackgroundFeng, W., Wan, X., Fan, S., Liu, C., Zheng, X., Liu, Q., Liu, M.-Y., Liu, X., Lin, C., Zhang, L., et al. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e15867 · Cited by 17
“RORγt is regarded as an important pathway for Th17 differentiation through medicating Th17 genes expression and producing IL-17A, IL-17F, and IL-22 in innate and adaptive immune cells [32,33] Previous studies confirmed that IL17/RORγt signalling inhibition could suppress Th17 cell differentiation and protect joints in…”
BackgroundEmerging roles of the Th17/IL-17-axis in glomerulonephritis
Ramani, K., & Biswas, P. S. (2015) · Cytokine · doi:10.1016/j.cyto.2015.07.029 · Cited by 17
Tanshinone IIA attenuates experimental autoimmune encephalomyelitis in rats
Yan, J., Yang, X., Han, D. K., & Feng, J. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5431 · Cited by 18
Schmidt, A. M., Paez-Cortez, J. R., Bryant, S. H., Westmoreland, S. V., Waegell, W., & Kingsbury, G. A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0182841 · Cited by 17
Tildrakizumab for the Treatment Of Psoriasis
Bangert, C., & Kopp, T. (2018) · Immunotherapy · doi:10.2217/imt-2018-0028 · Cited by 17
Cui, X., Gao, N., Me, R., Xu, J., & Yu, F. X. (2018) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.18-24672 · Cited by 17
“For example, IL17 is known as a strong inducer of antimicrobial peptides, particularly b-defensins(40) and S100A8/A9,(41) which can prevent infection at mucosal surfaces and in the skin.(42) IL-17A is the best-characterized member of the IL-17 family to date.”
BackgroundSpotlight on risankizumab and its potential in the treatment of plaque psoriasis: evidence to date
Machado, Á., & Torres, T. R. (2018) · Psoriasis Targets and Therapy · doi:10.2147/ptt.s165943 · Cited by 17
Lack of IL-17 Receptor A signaling aggravates lymphoproliferation in C57BL/6 lpr mice
Corneth, O. B. J., Schaper, F., Luk, F., Asmawidjaja, P. S., Mus, A. M. C., Horst, G., Heeringa, P., Hendriks, R. W., Westra, J., & Lubberts, E. (2019) · Scientific Reports · doi:10.1038/s41598-019-39483-w · Cited by 17
Cervantes‐Barragán, L., Cortez, V. S., Wang, Q., McDonald, K. G., Chai, J. N., Luccia, B. D., Gilfillan, S., Hsieh, C., Newberry, R. D., Sibley, L. D., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01423 · Cited by 17
Lay, C. S., Bridges, A. M., Goulding, J., Briddon, S. J., Soloviev, Z., Craggs, P. D., & Hill, S. J. (2021) · Cell chemical biology · doi:10.1016/j.chembiol.2021.05.002 · Cited by 17
“IL-23 acts as a pre-requisite for the activation of T helper 17 (Th17) cells and has additional pro-inflammatory effects on natural killer T, innate lymphoid, and gdT cell types (Gaffen et al., 2014).”
BackgroundORMDL3 regulates poly I:C induced inflammatory responses in airway epithelial cells
Laura, G., Liu, Y., Fernandes, K., Willis‐Owen, S. A. G., Ito, K., Cookson, W., Moffatt, M. F., & Zhang, Y. (2021) · BMC Pulmonary Medicine · doi:10.1186/s12890-021-01496-5 · Cited by 16
“The IL-23/Th17 pathway is a central component of cellular immunity and IL-17A is a signature cytokine of this pathway [19].”
Background
Metadata
- Authors
- Gaffen, S. L., Jain, R., Garg, A. V., & Cua, D. J.
- Affiliations
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- Corresponding author
- Cua, Daniel J.
- Venue
- Nature reviews. Immunology
- Published
- 2014-08-22
- Volume
- 14
- Issue
- 9
- Pages
- 585-600
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- PMC
- PMC4281037
- OpenAlex
- W2064645845
- Cited by
- 1,585
- References
- 187
- Citations by year
- 2026: 119 · 2025: 104 · 2024: 111 · 2023: 126 · 2022: 118 · 2021: 159 · 2020: 162 · 2019: 131 · 2018: 153 · 2017: 155 · 2016: 129 · 2015: 111 · 2014: 6
- FWCI
- 13.05
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases (R01AI107825, AI107825)
- National Institute of Dental and Craniofacial Research (R01DE022550, R01DE023815, DE022550)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › IL-33, ST2, and ILC Pathways
- Keywords
- IL-23, IL-17, Th17 cells, T cell lineage commitment, transcriptional regulation, IL-17 signaling, mesenchyme, immune-mediated inflammatory diseases, therapeutic antibodies
- MeSH terms
- Antibodies, Autoimmune Diseases, Epithelial Cells, Humans, Transcription, Genetic, Signal Transduction, Cytokines, Tight Junctions, Interleukin-17, Receptors, Interleukin-17, Interleukin-23, Th17 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.